Search General Info
Search Education
Search Partnering Companies

David Harel

Tel Aviv, Israel
David Harel is on a mission to improve patient outcomes and economics using data. He co-founded CytoReason in 2016 with the goal of leveraging new technology to address the increasing costs and complexity of bringing new therapies to the market.
CytoReason’s models are being used today by the largest pharma companies for drug discovery and development. David spent the first part of his career in private equity, focusing on strategy and financing of growth companies in industrial and Healthcare IT markets. David holds an undergraduate degree from Haifa University and an MBA from Carnegie Mellon.
Speaking In
[Available On-Demand]
CytoReason’s machine learning approach takes human clinical data and generates novel data-driven…